Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2000 Mar 7;162(5):641–645.

Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service

E R Wiebe 1, S E Comay 1, M McGregor 1, S Ducceschi 1
PMCID: PMC1231218  PMID: 10738449

Abstract

The sexual assault service, operated by the Children's & Women's Health Centre of British Columbia in partnership with the Vancouver General Hospital Emergency Department, started offering HIV prophylaxis in November 1996 to patients presenting to the emergency department after a sexual assault. In the first 16 months of the program a total of 258 people were seen by the service, of whom 71 accepted the offer of HIV prophylaxis. Only 29 continued with the drug treatment after receiving the initial 5-day starter pack, and only 8 completed the full 4-week treatment regmen and returned for their final follow-up visit. Patients at highest risk for HIV infection (those who had penetration by an assailant known to be HIV positive or at high risk for HIV infection [men who have sex with men, injection drug users]) were more likely to accept prophylaxis and more likely to complete the treatment than those at lower risk. Compliance and follow-up were the main problems with implementing this service. Service providers found it difficult to give the information about HIV prophylaxis to traumatized patients. After this program evaluation, the service changed its policy to offer HIV prophylaxis only to people at high risk of HIV infection. This targeting of services is expected to make the service providers' jobs easier and to make the program more cost-effective while still protecting sexual assault victims against HIV infection.

Full Text

The Full Text of this article is available as a PDF (242.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert J., Wahlberg J., Leitner T., Escanilla D., Uhlén M. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol. 1994 Sep;68(9):5918–5924. doi: 10.1128/jvi.68.9.5918-5924.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bamberger J. D., Waldo C. R., Gerberding J. L., Katz M. H. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med. 1999 Mar;106(3):323–326. doi: 10.1016/s0002-9343(99)00018-2. [DOI] [PubMed] [Google Scholar]
  3. Cardo D. M., Culver D. H., Ciesielski C. A., Srivastava P. U., Marcus R., Abiteboul D., Heptonstall J., Ippolito G., Lot F., McKibben P. S. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997 Nov 20;337(21):1485–1490. doi: 10.1056/NEJM199711203372101. [DOI] [PubMed] [Google Scholar]
  4. Claydon E., Murphy S., Osborne E. M., Kitchen V., Smith J. R., Harris J. R. Rape and HIV. Int J STD AIDS. 1991 May-Jun;2(3):200–201. doi: 10.1177/095646249100200310. [DOI] [PubMed] [Google Scholar]
  5. DeGruttola V., Seage G. R., 3rd, Mayer K. H., Horsburgh C. R., Jr Infectiousness of HIV between male homosexual partners. J Clin Epidemiol. 1989;42(9):849–856. doi: 10.1016/0895-4356(89)90098-x. [DOI] [PubMed] [Google Scholar]
  6. FitzGerald J. M., Patrick D. M., Strathdee S., Rekart M., Elwood R. K., Schecter M. T., Montaner J., O'Shaughnessy M. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group. Int J Tuberc Lung Dis. 1999 Feb;3(2):153–155. [PubMed] [Google Scholar]
  7. Gostin L. O., Lazzarini Z., Alexander D., Brandt A. M., Mayer K. H., Silverman D. C. HIV testing, counseling, and prophylaxis after sexual assault. JAMA. 1994 May 11;271(18):1436–1444. [PubMed] [Google Scholar]
  8. Hogg R. S., Strathdee S. A., Craib K. J., O'Shaughnessy M. V., Montaner J. S., Schechter M. T. Modelling the impact of HIV disease on mortality in gay and bisexual men. Int J Epidemiol. 1997 Jun;26(3):657–661. doi: 10.1093/ije/26.3.657. [DOI] [PubMed] [Google Scholar]
  9. Jenny C., Hooton T. M., Bowers A., Copass M. K., Krieger J. N., Hillier S. L., Kiviat N., Corey L., Stamm W. E., Holmes K. K. Sexually transmitted diseases in victims of rape. N Engl J Med. 1990 Mar 15;322(11):713–716. doi: 10.1056/NEJM199003153221101. [DOI] [PubMed] [Google Scholar]
  10. Kapiga S. H., Shao J. F., Lwihula G. K., Hunter D. J. Risk factors for HIV infection among women in Dar-es-Salaam, Tanzania. J Acquir Immune Defic Syndr. 1994 Mar;7(3):301–309. [PubMed] [Google Scholar]
  11. Kirkham C. M., Lobb D. J. The British Columbia Positive Women's Survey: a detailed profile of 110 HIV-infected women. CMAJ. 1998 Feb 10;158(3):317–323. [PMC free article] [PubMed] [Google Scholar]
  12. Lauber A. A., Souma M. L. Use of toluidine blue for documentation of traumatic intercourse. Obstet Gynecol. 1982 Nov;60(5):644–648. [PubMed] [Google Scholar]
  13. Ledray L. E. The sexual assault examination: overview and lessons learned in one program. J Emerg Nurs. 1992 Jun;18(3):223–230. [PubMed] [Google Scholar]
  14. López-Varela M., García-Rodríguez J., Martínez-Zapico R. Low risk of HIV transmission in rape victims. Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):622–622. doi: 10.1007/BF01971320. [DOI] [PubMed] [Google Scholar]
  15. Mellors J. W., Kingsley L. A., Rinaldo C. R., Jr, Todd J. A., Hoo B. S., Kokka R. P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995 Apr 15;122(8):573–579. doi: 10.7326/0003-4819-122-8-199504150-00003. [DOI] [PubMed] [Google Scholar]
  16. Padian N. S., Shiboski S. C., Glass S. O., Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol. 1997 Aug 15;146(4):350–357. doi: 10.1093/oxfordjournals.aje.a009276. [DOI] [PubMed] [Google Scholar]
  17. Pinkerton S. D., Holtgrave D. R., Bloom F. R. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS. 1998 Jun 18;12(9):1067–1078. [PubMed] [Google Scholar]
  18. Royce R. A., Seña A., Cates W., Jr, Cohen M. S. Sexual transmission of HIV. N Engl J Med. 1997 Apr 10;336(15):1072–1078. doi: 10.1056/NEJM199704103361507. [DOI] [PubMed] [Google Scholar]
  19. Slaughter L., Brown C. R., Crowley S., Peck R. Patterns of genital injury in female sexual assault victims. Am J Obstet Gynecol. 1997 Mar;176(3):609–616. doi: 10.1016/s0002-9378(97)70556-8. [DOI] [PubMed] [Google Scholar]
  20. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]
  21. Wilkins R. Use of postal codes and addresses in the analysis of health data. Health Rep. 1993;5(2):157–177. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES